is glp 1 safe for non diabetics GLP-1 Weight Loss Non-Diabetics: Clinical Guide GLP-1 receptor agonists | How

Nat Med 21:2736

GLP-1 agonists were originally approved to treat Type 2 Diabetes (T2D) but their most recent incarnations, which consist of both next generation GLP-1s and combinations (Ozempic, Mounjaro, Wegovy, Zepbound), have moved beyond the realm of T2D into the treatment of obesity

How PlexusDx Supports a More Personalized Approach PlexusDx recognizes that GLP-1 timing safety is not one-size-fits-all

And because both obesity and diabetes are chronic conditions, stopping the medication often reverses the gains, sending weight and blood sugar creeping back

Encouraging the development of more detailed patient information leaflets and consent forms that clearly communicate the risks associated with semaglutide

Kooshesh, L., Nateghian, Z